| DB ID | MyCo_1086 |
| Title | Risk factors and impact of beta-D glucan on invasive fungal infection for the living donor liver transplant recipients |
| Year | 2006 |
| PMID | 16778367 |
| Fungal Diseases involved | Invasive fungal infection |
| Associated Medical Condition | Living Donor Liver Transplant Recipients |
| Genus | Candida |
| Species | parapsilosis |
| Organism | Candida parapsilosis |
| Ethical Statement | This program was approved by the ethics committees in the hospital, Graduate School of Medicine, Tohoku University, Sendai, Japan and the patients were given informed consent about the LDLT. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | During the study period, mycoses were detected in 48 patients (50.0%) before LDLT, in 63 (65.6%) after LDLT, and in 38 (39.6%) patients during both periods. |
| Cohort No. | 111 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | BDG assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | BDG Assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
